Member Info for Laura2022

Positions been taken last 5 weeks

Feels this afternoon more heavy buying..partic for a Friday

All afternoon

Could easily buy £10k earlier in week , now NT for £10k

0.661 sell , 662 buy

Very tight

Now wanting higher

86kb

Also been buying TRT

Added 4574 shown as a sell at 65.5

Yes actually sell price is 65.6

Great bear

Can sell 15,000 at 65.6p

Final purchase today

Now 2p+ please

TTC

Most oversold in over 3yrs

Small cap of less than £10mln

Solid business, where end year cash always been £1mln+ for last 4yrs

Accordingly, the Company now expects that Group revenue for FY26 will be not less than £5.2m, including approximately £2.0m of royalty income

Plus c £1mln cash

Wow

65 5p buy

65 6p sell

Must be buy order TRT as was NT to sell for 2 days but now 65.6p bid for plenty

Now up 100% somce buying last summer

£20k buy

Not me But I'll be adding more today

No stock at 14p

15%

Ebitda in 2021 when offer was made was £160mln

Now in 2025 its £270/280mln

Imho only something like £3.00-3.50 would be acceptable

Published on February 5, 2026

by Simon Thompson

Moreover, Goldplat’s net cash of £6.1mn (30 June 2025) is forecast to increase to £8.4mn by the same point this year, buoyed by the improved operating performance and cash generation. That sum equates to 42 per cent of the company’s market capitalisation of £20.1mn. On this basis, Goldplat’s enterprise valuation of £11.7mn equates to twice operating profit estimates of £5.9mn

The shares offer a decent income, too. The board has started paying dividends and declared an interim payout of 0.117p per share in December 2025. Based on Zeus’ full-year dividend per share estimate of 0.2p, the shares offer a prospective dividend yield of 1.7 per cent.

Sum-of-the-parts valuation

If you value Goldplat’s recovery operations on a more sensible multiple of five times operating profit estimates of £5.9mn for the current financial year, this implies a standalone valuation of £29.5mn (17.25p). Then there is the net cash, which is forecast to rise to £8.4mn (4.9p) by mid-year, or possibly even higher if the company exceeds analysts’ earnings expectations.

On this basis, a fair valuation of 22p for the equity – or almost double the share price – is a reasonable target. Zeus’ conservative fair valuation of 15.1p (pre-upgrades) still offers material upside to the current share price. Buy.

Bodes well

Not wasting my time

Filtered